Ardent Health (ARDT) Projected to Post Quarterly Earnings on Wednesday

Ardent Health (NYSE:ARDT) is anticipated to post its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.35 per share for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 5, 2026 at 10:00 AM ET.

Ardent Health Trading Up 2.0%

Shares of ARDT opened at $9.80 on Wednesday. Ardent Health has a twelve month low of $8.07 and a twelve month high of $15.59. The company has a quick ratio of 1.95, a current ratio of 2.08 and a debt-to-equity ratio of 0.67. The stock has a market cap of $1.40 billion, a PE ratio of 6.76, a P/E/G ratio of 5.56 and a beta of 0.72. The business’s 50-day moving average price is $8.84 and its 200-day moving average price is $11.20.

Institutional Investors Weigh In On Ardent Health

Hedge funds have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd lifted its stake in shares of Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after purchasing an additional 2,638 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in Ardent Health in the 3rd quarter worth $61,000. New York State Common Retirement Fund raised its holdings in shares of Ardent Health by 121.4% during the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after acquiring an additional 3,400 shares in the last quarter. Squarepoint Ops LLC purchased a new position in shares of Ardent Health in the third quarter valued at $145,000. Finally, Fox Run Management L.L.C. bought a new stake in shares of Ardent Health in the 4th quarter worth about $147,000.

Analyst Upgrades and Downgrades

ARDT has been the topic of a number of recent analyst reports. Guggenheim lowered their price objective on Ardent Health from $18.00 to $15.00 and set a “buy” rating on the stock in a research report on Tuesday, November 18th. Truist Financial cut their target price on Ardent Health from $21.00 to $13.00 and set a “buy” rating for the company in a research note on Friday, November 14th. JPMorgan Chase & Co. decreased their target price on shares of Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 20th. Stephens lowered their price objective on Ardent Health from $21.00 to $17.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Finally, UBS Group reduced their price target on Ardent Health from $14.50 to $14.00 and set a “buy” rating on the stock in a report on Thursday, December 18th. Six equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Ardent Health presently has an average rating of “Hold” and an average target price of $14.58.

Ardent Health News Summary

Here are the key news stories impacting Ardent Health this week:

• Neutral Sentiment: Multiple national plaintiff firms are actively soliciting Ardent investors and reminding holders of the March 9, 2026 lead‑plaintiff deadline — a procedural development that increases class‑action activity but does not itself create new allegations. ROSEN: ARDT Final Deadline
• Negative Sentiment: Allegations of undisclosed collections problems and related securities‑fraud claims have been publicized by several firms; one complaint ties prior company statements to a sharp (~33%) stock decline and seeks lead plaintiffs for a federal action pending in the Middle District of Tennessee — this increases litigation and reputational risk for ARDT. KSF: Securities Fraud Class Action
• Negative Sentiment: Hagens Berman and other firms highlight an alleged “$97M accounting shock” and the company’s prior use of a rigid “180‑day cliff” to reserve uncollectible accounts — if true, this could imply material prior misstatements, greater reserve volatility, or future restatements that would materially affect earnings and leverage. Hagens Berman: $97M Accounting Shock

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.